Citadel Investment Advisory’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,159
Closed -$49K 78
2026
Q1
$49K Sell
2,159
-598
-22% -$14.1K 0.02% 77
2025
Q4
$73K Sell
2,757
-132
-5% -$3.9K 0.03% 77
2025
Q3
$91K Hold
2,889
0.04% 79
2025
Q2
$91K Sell
2,889
-166
-5% -$5.49K 0.04% 79
2025
Q1
$134K Hold
3,055
0.07% 77
2024
Q4
$134K Sell
3,055
-142
-4% -$6.24K 0.07% 77
2024
Q3
$138K Sell
3,197
-397
-11% -$17.7K 0.07% 79
2024
Q2
$162K Sell
3,594
-1,161
-24% -$60.3K 0.09% 76
2024
Q1
$297K Sell
4,755
-33
-0.7% -$1.98K 0.17% 69
2023
Q4
$268K Sell
4,788
-172
-3% -$8.57K 0.16% 72
2023
Q3
$262K Hold
4,960
0.17% 71
2023
Q2
$318K Sell
4,960
-166
-3% -$9.45K 0.21% 67
2023
Q1
$274K Sell
5,126
-100
-2% -$5.79K 0.19% 70
2022
Q4
$280K Sell
5,226
-82
-2% -$4.23K 0.19% 67
2022
Q3
$245K Sell
5,308
-16,234
-75% -$880K 0.19% 70
2022
Q2
$937K Buy
21,542
+12,072
+127% +$778K 0.64% 39
2022
Q1
$649K Buy
+9,470
New +$675K 0.38% 54

Other funds holding ENOV

Citadel Investment Advisory's ENOV Position: Q2 2026 in Review

Citadel Investment Advisory sold out of Enovis (ENOV) in Q2 2026, closing a stake of 2,159 shares — an estimated $49K sold.

Citadel Investment Advisory first reported a position in ENOV in Q1 2022 and held it in 17 quarters. The position peaked at $937K in Q2 2022. 57 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Citadel Investment Advisory reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
  • Citadel Investment Advisory sold 2,159 Enovis shares in Q2 2026, an estimated $49K.
  • Citadel Investment Advisory first reported a position in Enovis in Q1 2022 and held it in 17 quarters.
  • Citadel Investment Advisory's Enovis position peaked at $937K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Citadel Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.